Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Schering-Plough presents new agents for cognitive disorders

April 2, 1998

Effects of MKC-242 on cholinergic neurons examined using in vivo microdialysis

April 1, 1998

MCI-225: neurochemical profile of a novel antidepressant

April 1, 1998

OPC-24439, a new sigma-receptor ligand, suppresses hippocampal neuronal activity

April 1, 1998

Synthelabo claims compounds with selective affinity for certain GABA-A receptors

April 1, 1998

NOS inhibitors claimed by Schering AG for CNS disorders

April 1, 1998

Zeneca in-licenses novel chiral anesthetic agent

April 1, 1998

Melatonin may be involved in the hypnotic activity of zaleplon

March 31, 1998

Sumitomo presents new NHE inhibitor with neuroprotective effects

March 31, 1998

Excitatory amino acid receptor antagonists related to PNQX reported at ACS

March 30, 1998

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...